Home › Ulcerative Colitis › California
Ulcerative Colitis clinical trials in California
41 studies for Ulcerative Colitis are looking for participants at sites in California.
Cities in California
- San Diego16 studies
- Los Angeles13 studies
- Mountain View8 studies
- Lancaster8 studies
- Anaheim7 studies
- Westminster5 studies
- San Francisco4 studies
- Victorville4 studies
- Orange3 studies
- San Bernardino3 studies
- Newport Beach3 studies
- Oxnard3 studies
- Chula Vista3 studies
- Murrieta3 studies
- Thousand Oaks3 studies
- Garden Grove3 studies
- Folsom3 studies
- Sacramento3 studies
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-018, San Diego
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 29, 2026 · NCT07845487Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Clinnova Research /ID# 280509, Anaheim
- Southern California Res. Ctr /ID# 280476, Coronado
- Gastro Care Institute /ID# 281071, Lancaster
- and 2 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 29, 2026 · NCT07697456A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 024, Canoga Park
- Site 023, La Jolla
- Site 012, Lancaster
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 29, 2026 · NCT07012395Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Palo Alto
RecruitingPhase 1/2Healthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Sep 29, 2026 · NCT06619990A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Gastro Care Institute, Lancaster
- Medical Associates Research Group, Inc., San Diego
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06979336A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- Clinnova Research ( Site 1042), Anaheim
- Southern California Research Center ( Site 1044), Coronado
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 28, 2026 · NCT07463183A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Clinnova Research, Anaheim
- Southern California Research Center, Coronado
- Om Research LLC, Lancaster
- and 7 more
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT07196748A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Loma Linda University Health System, Loma Linda
- Cedars-Sinai Medical Center, Los Angeles
- Lucile Packard Children's Hospital, Palo Alto
- and 1 more
RecruitingPhase 2/3
Ages 2 to 17 · All sexes · Updated Sep 24, 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Smart Cures Clinical Research, Anaheim
- Cedars-Sinai Medical Center, Beverly Hills
- United Medical Doctors - Los Alamitos, Los Alamitos
- and 1 more
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 24, 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Biopharma Informatic, LLC, Los Angeles
- Om Research LLC, Oxnard
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07483073LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Clinnova Research, Anaheim
- GMC Clinical Research, Folsom
- Om Research LLC, Temple City
- and 1 more
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07415044LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Clinnova Research - Anaheim, Anaheim
- Om Research LLC, Lancaster
- Biopharma Informatic, LLC, Los Angeles
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07186101A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- UCSF Medical Center at Mission Bay, San Francisco
RecruitingPhase 3
Ages 2 to 19 · All sexes · Updated Sep 22, 2026 · NCT04844606A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Rady Children's Hospital /ID# 271873, San Diego
- University of California San Francisco - Mission Bay /ID# 273022, San Francisco
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Sep 22, 2026 · NCT07071519A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Cedars-Sinai Medical Center, Los Angeles
- Hoag Hospital Newport Beach, Newport Beach
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Sep 21, 2026 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Southern California GI & Liver Centers - Site Number: 8400062, Coronado
- United Medical Doctors CA - Site Number: 8400044, Murrieta
- Om Research, LLC - Victorville - Site Number: 8400022, Victorville
RecruitingPhase 3
Ages 16 to 80 · All sexes · Updated Sep 15, 2026 · NCT07185009A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastroenterology and Liver Institute, Escondido
- United Clinical Research Institute, Murrieta
RecruitingPhase 4
Ages 18 to 80 · All sexes · Updated Sep 15, 2026 · NCT06581328A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Clinnova Research, Anaheim
- Gastro SB Clinic, Chula Vista
- United Medical Doctors, Los Alamitos
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT07577856An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- FOMAT - Unio Specialty Care Arcadia - Site Number: 8400027, Arcadia
- Alliance Research Institute - Site Number: 8400008, Canoga Park
- Southern California GI & Liver Centers - Site Number: 8400062, Coronado
- and 13 more
RecruitingPhase 3
Ages 16 to 80 · All sexes · Updated Aug 20, 2026 · NCT07184996Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis
- Vanda Investigational Site, Chula Vista
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 18, 2026 · NCT07686081Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensity Focused Electromagnetic Stimulation
- Cedars Sinai Medical Center, Los Angeles
Recruiting
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT07034443Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Hoag Hospital, Irvine
- UC San Diego Health, La Jolla
- Cedars-Sinai, Los Angeles
- and 1 more
Recruiting
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT05230173BOOM-IBD2 Pivotal Clinical Trial
- Gastroenterology Medical Clinic (Objective Health), Folsom
- Center for Colorectal Innovation, Los Angeles
- Hoag Hospital, Newport Beach
- and 1 more
Recruiting
Ages 18 to 85 · All sexes · Updated Aug 6, 2026 · NCT06571669A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Children's Hospital Of Orange County, Orange
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Aug 3, 2026 · NCT06100289A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Erick Alayo Medical Corp/Gastro SB Clinic, Chula Vista
- Southern California GI and Liver Centers (SCLC), Coronado
- Valley View Research, Garden Grove
- and 6 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Jul 30, 2026 · NCT06598943An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Scripps Clinic Torrey Pines, La Jolla
- United Medical Doctors, Los Alamitos
- United Medical Doctors, Los Alamitos
RecruitingObservational study
Ages 18 to 64 · All sexes · Updated Jul 9, 2026 · NCT06398626A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- Valley View Wellness Medical Center, Garden Grove
- Loma Linda Children's Hospital, Loma Linda
- Loma Linda University Clinical Trial Center, Loma Linda
- and 7 more
RecruitingPhase 2
Ages 12 to 17 · All sexes · Updated Jul 8, 2026 · NCT05287126A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Loma Linda University, Loma Linda
- Children's Hospital of Orange County, Orange
- Stanford Children's Health, Palo Alto
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Jun 22, 2026 · NCT06405087R-3750 in Patients With Mild to Moderate Ulcerative Colitis
- Amicis Research Center, Valencia
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jun 12, 2026 · NCT05666960The Use of Butyrate Therapy in Pediatric Ulcerative Colitis
- Children's Hospital Los Angeles, Los Angeles
RecruitingPhase 2
Ages 7 to 21 · All sexes · Updated Jun 4, 2026 · NCT05218850A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Rady Children's Hospital - San Diego - PIN, San Diego
RecruitingPhase 3
Ages 2 and older · All sexes · Updated May 7, 2026 · NCT05442567A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
- Investigational Site Number: 8400009, Escondido
- Investigational Site Number: 8400006, Lancaster
- Investigational Site Number: 8400025, Thousand Oaks
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Apr 23, 2026 · NCT06975722Fermented Food-Supplemented Diet in Ulcerative Colitis
- Stanford University, Palo Alto
Recruiting
Ages 18 and older · All sexes · Updated Feb 27, 2026 · NCT04401605The Influence of a Fasting Mimicking Diet on Ulcerative Colitis
- Stanford University, Palo Alto
Recruiting
Ages 18 to 70 · All sexes · Updated Feb 27, 2026 · NCT03615690Impact of Prebiotics in Ulcerative Colitis
- UCLA, Los Angeles
Recruiting
Ages 18 to 85 · All sexes · Updated Feb 27, 2026 · NCT06495658Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- University of Los Angeles Health, Los Angeles
Recruiting
Ages 18 to 85 · All sexes · Updated Jan 8, 2026 · NCT05987852Effects of Pomegranate Juice on Ulcerative Colitis
- West Los Angeles VA Medical Center, Los Angeles
- UCLA Center for Human Nutrition, Los Angeles
Recruiting
Ages 18 and older · All sexes · Updated Dec 9, 2025 · NCT07115862Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
- Bausch Health Site 008, Garden Grove
RecruitingPhase 4
Ages 5 to 17 · All sexes · Updated Sep 16, 2025 · NCT04314375Understanding Ozanimod's MOA Via Mass Cytometry in Ulcerative Colitis
- University of California San Diego, San Diego
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 15, 2024 · NCT06311123From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.